Wright, K. D., Zimmerman, M. A., Fine, E., Aspri, T., Kieran, M. W., & Chi, S. (2018). LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY. Neuro Oncol.

Wright, Karen D., Mary Ann Zimmerman, Elizabeth Fine, Tristan Aspri, Mark W. Kieran, و Susan Chi. "LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY." Neuro Oncol 2018.

Wright, Karen D., et al. "LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY." Neuro Oncol 2018.